• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

原发性高草酸尿症调查中草酸盐排泄与草酸盐:肌酐比值的可比性:来自转诊中心的数据回顾

The comparability of oxalate excretion and oxalate:creatinine ratio in the investigation of primary hyperoxaluria: review of data from a referral centre.

作者信息

Clifford-Mobley Oliver, Tims Christopher, Rumsby Gill

机构信息

Department of Clinical Biochemistry, UCLH, London, UK

Department of Clinical Biochemistry, UCLH, London, UK.

出版信息

Ann Clin Biochem. 2015 Jan;52(Pt 1):113-21. doi: 10.1177/0004563214529937. Epub 2014 Apr 9.

DOI:10.1177/0004563214529937
PMID:24719216
Abstract

BACKGROUND

Urine oxalate measurement is an important investigation in the evaluation of renal stone disease. Primary hyperoxaluria (PH) is a rare inherited metabolic disease characterised by persistently elevated urine oxalate, but the diagnosis may be missed in adults until renal failure has developed. Urine oxalate results were reviewed to compare oxalate:creatinine ratio and oxalate excretion, and to estimate the potential numbers of undiagnosed PH.

METHODS

Urine oxalate results from August 2011 to April 2013 were reviewed. Oxalate excretion and oxalate:creatinine ratio were evaluated for 24 h collections and ratio alone for spot urine samples.

RESULTS

Oxalate:creatinine ratio and oxalate excretion were moderately correlated (R=0.63) in 24-h urine collections from patients aged 18 years and above. Sex-related differences were found requiring implementation of male and female reference ranges for oxalate:creatinine ratio. Of samples with both ratio and excretion above the reference range, 7% came from patients with confirmed PH. There were 24 patients with grossly elevated urine oxalate who had not been evaluated for PH.

CONCLUSIONS

Oxalate:creatinine ratio and oxalate excretion were discordant in many patients, which is likely to be a result of intra-individual variation in creatinine output and imprecision in the collection itself. Some PH patients had urine oxalate within the reference range on occasion, and therefore it is not possible to exclude PH on the finding of a single normal result. A significant number of individuals had urine oxalate results well above the reference range who potentially have undiagnosed PH and are consequently at risk of renal failure.

摘要

背景

尿草酸测定是评估肾结石疾病的一项重要检查。原发性高草酸尿症(PH)是一种罕见的遗传性代谢疾病,其特征是尿草酸持续升高,但在成年人中,直到出现肾衰竭才可能漏诊。回顾尿草酸检测结果,以比较草酸/肌酐比值和草酸排泄量,并估计未确诊的PH潜在病例数。

方法

回顾2011年8月至2013年4月的尿草酸检测结果。对24小时尿液收集样本评估草酸排泄量和草酸/肌酐比值,对随机尿样本仅评估比值。

结果

在18岁及以上患者的24小时尿液收集中,草酸/肌酐比值与草酸排泄量呈中度相关(R=0.63)。发现存在性别差异,需要分别制定男性和女性草酸/肌酐比值的参考范围。在比值和排泄量均高于参考范围的样本中,7%来自确诊为PH的患者。有24例尿草酸严重升高的患者未接受PH评估。

结论

许多患者的草酸/肌酐比值和草酸排泄量不一致,这可能是由于个体内肌酐生成量的变化以及收集过程本身的不精确性所致。一些PH患者偶尔尿草酸在参考范围内,因此,不能仅凭一次正常结果排除PH。大量个体的尿草酸结果远高于参考范围,他们可能患有未确诊的PH,因此有肾衰竭风险。

相似文献

1
The comparability of oxalate excretion and oxalate:creatinine ratio in the investigation of primary hyperoxaluria: review of data from a referral centre.原发性高草酸尿症调查中草酸盐排泄与草酸盐:肌酐比值的可比性:来自转诊中心的数据回顾
Ann Clin Biochem. 2015 Jan;52(Pt 1):113-21. doi: 10.1177/0004563214529937. Epub 2014 Apr 9.
2
Urine oxalate biological variation in patients with primary hyperoxaluria.原发性高草酸尿症患者尿草酸的生物学变异。
Urolithiasis. 2016 Aug;44(4):333-7. doi: 10.1007/s00240-016-0860-2. Epub 2016 Feb 8.
3
The urinary response to an oral oxalate load in recurrent calcium stone formers.复发性草酸钙结石患者口服草酸盐负荷后的尿液反应。
J Urol. 2003 Jun;169(6):2030-3. doi: 10.1097/01.ju.0000062527.37579.49.
4
Efficacy and safety of Oxalobacter formigenes to reduce urinary oxalate in primary hyperoxaluria.产甲酸草酸杆菌降低原发性高草酸尿症患者尿草酸的疗效和安全性。
Nephrol Dial Transplant. 2011 Nov;26(11):3609-15. doi: 10.1093/ndt/gfr107. Epub 2011 Apr 2.
5
Evaluation of a high-performance liquid chromatography method for urinary oxalate determination and investigation regarding the pediatric reference interval of spot urinary oxalate to creatinine ratio for screening of primary hyperoxaluria.高效液相色谱法测定尿草酸盐的评价及尿草酸盐/肌酐比值在儿童原发性高草酸尿症筛查中的参考区间研究。
J Clin Lab Anal. 2021 Aug;35(8):e23870. doi: 10.1002/jcla.23870. Epub 2021 Jun 7.
6
Determination of oxalate excretion in spot urines of healthy children by ion chromatography.采用离子色谱法测定健康儿童随机尿样中的草酸盐排泄量。
Eur J Clin Chem Clin Biochem. 1994 Jan;32(1):27-9. doi: 10.1515/cclm.1994.32.1.27.
7
[Evaluation of oxalate/creatinine ratio in the second morning urine sample of health school children].[健康学龄儿童晨尿样本中草酸/肌酐比值的评估]
Pol Merkur Lekarski. 2001 Apr;10(58):271-3.
8
Metabolic profile and impact of diet in patients with primary hyperoxaluria.原发性高草酸尿症患者的代谢特征及饮食影响
Int Urol Nephrol. 2018 Sep;50(9):1583-1589. doi: 10.1007/s11255-018-1939-1. Epub 2018 Jul 23.
9
Hyperoxaluria in idiopathic calcium nephrolithiasis--what are the limits?特发性钙肾结石中的高草酸尿症——其限度是什么?
Scand J Urol Nephrol. 1999 Dec;33(6):368-71.
10
Fractional oxalate clearance in subjects with normal and impaired renal function.
Nephron. 1985;41(1):78-81. doi: 10.1159/000183551.

引用本文的文献

1
Establishment of adult reference interval of oxalate in spot urine using real-world data.利用真实世界数据建立随机尿草酸的成人参考区间。
Eur J Med Res. 2025 May 24;30(1):415. doi: 10.1186/s40001-025-02657-6.
2
Optimizing Screening Performance for the Risk of Hyperoxaluria and Urolithiasis Using the Urinary Oxalate/Creatinine Ratio: A Retrospective Analysis.使用尿草酸/肌酐比值优化高草酸尿症和尿石症风险的筛查性能:一项回顾性分析。
Eur Urol Open Sci. 2025 Mar 28;75:20-28. doi: 10.1016/j.euros.2025.03.003. eCollection 2025 May.
3
Efficacy and safety of lumasiran for infants and young children with primary hyperoxaluria type 1: 30-month analysis of the phase 3 ILLUMINATE-B trial.
鲁马西拉对1型原发性高草酸尿症婴幼儿的疗效和安全性:3期ILLUMINATE-B试验的30个月分析
Front Pediatr. 2024 Sep 16;12:1392644. doi: 10.3389/fped.2024.1392644. eCollection 2024.
4
Multicenter Long-Term Real World Data on Treatment With Lumasiran in Patients With Primary Hyperoxaluria Type 1.关于鲁马西拉治疗1型原发性高草酸尿症患者的多中心长期真实世界数据。
Kidney Int Rep. 2023 Oct 6;9(1):114-133. doi: 10.1016/j.ekir.2023.10.004. eCollection 2024 Jan.
5
Natural history of urine and plasma oxalate in children with primary hyperoxaluria type 1.儿童 1 型原发性高草酸尿症尿液和血浆草酸盐的自然史。
Pediatr Nephrol. 2024 Jan;39(1):141-148. doi: 10.1007/s00467-023-06074-x. Epub 2023 Jul 17.
6
Clinical practice recommendations for primary hyperoxaluria: an expert consensus statement from ERKNet and OxalEurope.原发性高草酸尿症临床实践建议:来自欧洲罕见肾脏病网络(ERKNet)和欧洲草酸尿症协会(OxalEurope)的专家共识声明
Nat Rev Nephrol. 2023 Mar;19(3):194-211. doi: 10.1038/s41581-022-00661-1. Epub 2023 Jan 5.
7
Efficacy and safety of lumasiran for infants and young children with primary hyperoxaluria type 1: 12-month analysis of the phase 3 ILLUMINATE-B trial.Lumasiran 治疗 1 型原发性高草酸尿症婴儿和幼儿的疗效和安全性:III 期 ILLUMINATE-B 试验的 12 个月分析。
Pediatr Nephrol. 2023 Apr;38(4):1075-1086. doi: 10.1007/s00467-022-05684-1. Epub 2022 Aug 1.
8
Case Report: Sustained Efficacy of Lumasiran at 18 Months in Primary Hyperoxaluria Type 1.病例报告:鲁马西拉在1型原发性高草酸尿症中18个月的持续疗效
Front Pediatr. 2022 Jan 5;9:791616. doi: 10.3389/fped.2021.791616. eCollection 2021.
9
Relationship of spot urine oxalate to creatinine ratio and 24 hours urinary oxalate excretion in patients with urolithiasis.尿石症患者随机尿草酸与肌酐比值和24小时尿草酸排泄量的关系。
Ann Med Surg (Lond). 2020 Nov 7;60:330-333. doi: 10.1016/j.amsu.2020.11.002. eCollection 2020 Dec.
10
Absence of the sulfate transporter SAT-1 has no impact on oxalate handling by mouse intestine and does not cause hyperoxaluria or hyperoxalemia.SAT-1 硫酸盐转运蛋白缺失对小鼠肠道草酸盐处理没有影响,也不会导致高草酸尿症或高草酸血症。
Am J Physiol Gastrointest Liver Physiol. 2019 Jan 1;316(1):G82-G94. doi: 10.1152/ajpgi.00299.2018. Epub 2018 Nov 1.